The

health care

sector closed the day up 1.2%.

Questcor Pharmaceuticals Inc

(

QCOR

),

Tibet Pharmaceuticals Inc

(

TBET

),

OxiGene Inc

(

OXGN

), and

Abaxis Inc

(

ABAX

) were all winners today within the health care sector with

Johnson & Johnson

(

JNJ

) being today's featured health care winner. Johnson & Johnson rose 80 cents (1.3%) to $64.49 on light volume. Throughout the day, 9.9 million shares of Johnson & Johnson exchanged hands as compared to its average daily volume of 15.8 million shares.

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Johnson & Johnson has a market cap of $177.4 billion and is part of the

drugs

industry. The company has a P/E ratio of 13.2, below the average drugs industry P/E ratio of 15.8 and below the S&P 500 P/E ratio of 17.7. Shares are up 3% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Johnson & Johnson as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front,

Human Genome Sciences Inc

(

HGSI

),

Spherix Inc

(

SPEXD

),

Spherix Inc

(

SPEX

), and

Albany Molecular Research Inc

(

AMRI

) were all losers within the health care sector with

Vertex Pharmaceuticals

(

VRTX

) being today's health care sector Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null